Glucose tolerance in mice is linked to the dose of the p53 transactivation domain

Endocrine Research

Volumn 38, Issue 3, 2013, Pages 139-150

  Franck, Debra ^a,b   Tracy, Laura ^a,b   Armata, Heather L ^a   Delaney, Christine L ^a   Jung, Dae Young ^a   Ko, Hwi Jin ^a   Ong, Helena ^a   Kim, Jason K ^a   Scrable, Heidi ^a   Sluss, Hayla K ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WORCESTER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Glucose intolerance; Mouse genetics; P53

Indexed keywords

PROTEIN P44; PROTEIN P53; PROTEIN ZPF385A; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRESS; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MALE; METABOLIC PARAMETERS; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSACTIVATION;

EID: 84879510561     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.3109/07435800.2012.735735     Document Type: Article

References (35)

1. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J 1995;14:1136-1144
2. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 2005;96:667-674 (Pubitemid 40478334)
3. Moon C, Kim S, Wie M, et al. Increased expression of p53 and Bax in the spinal cords of rats with experimental autoimmune encephalomyelitis. Neurosci Lett 2000;289:41-44 (Pubitemid 30433841)
4. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS. p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 1994;91:7525-7529 (Pubitemid 24238217)
5. van Vlijmen BJ, Gerritsen G, Franken AL, et al. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE. 3-Leiden transgenic mice. Circ Res 2001;88:780-786 (Pubitemid 32429973)
6. Yamanishi Y, Boyle DL, Pinkoski MJ, et al. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol 2002;160:123-130 (Pubitemid 34052273)
7. Yeung SJ, Pan J, Lee MH. Roles of p53, MYC and HIF-1 in regulating glycolysis-the seventh hallmark of cancer. Cell Mol Life Sci 2008;65:3981-3999
8. Fiordaliso F, Leri A, Cesselli D, et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001;50:2363-2375 (Pubitemid 33641924)
9. Keim AL, Chi MM, Moley KH. Hyperglycemia-induced apoptotic cell death in the mouse blastocyst is dependent on expression of p53. Mol Reprod Dev 2001;60:214-224 (Pubitemid 32847132)
10. Gottlieb E, Vousden KH. p53 regulation of metabolic pathways. Cold Spring Harb Perspect Niol 2010;50: A001040
11. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004;64:2627-2633 (Pubitemid 38523921)
12. Werner H, Karnieli E, Rauscher FJ, LeRoith D. Wild-Type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 1996;93:8318-8323 (Pubitemid 26269555)
13. Jiang P, Du W, Wang X, et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol 2011;13:310-316
14. Matoba S, Kang JG, Patino WD, et al. p53 regulates mitochondrial respiration. Science 2006;312:1650-1653 (Pubitemid 43902663)
15. Kawagishi H, Wakoh T, Uno H, et al. Hzf regulates adipogenesis through translational control of C/EBPalpha. EMBO J 2008;27:1481-1490 (Pubitemid 351733331)
16. Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009;15:1082-1087
17. Zheng SJ, Lamhamedi-Cherradi SE, Wang P, Xu L, Chen YH. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 2005;54:1423-1428 (Pubitemid 40586673)
18. Bar RS, Levis WR, Rechler MM, et al. Extreme insulin resistance in ataxia telangiectasia: Defect in affinity of insulin receptors. N Engl J Med 1978;298:1164-1171 (Pubitemid 8356481)
19. Miles PD, Treuner K, Latronica M, Olefsky JM, Barlow C. Impaired insulin secretion in a mouse model of ataxia telangiectasia. Am J Physiol Endocrinol Metab 2007;293:E70-74 (Pubitemid 47105918)
20. Schalch DS, McFarlin DE, Barlow MH. An unusual form of diabetes mellitus in ataxia telangiectasia. N Engl J Med 1970;282:1396-1402
21. Schneider JG, Finck BN, Ren J, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 2006;4:377-389 (Pubitemid 44645067)
22. Yang DQ, Kastan MB. Participation of ATM in insulin signalling through phosphorylation of eIF-4Ebinding protein 1. Nat Cell Biol 2000;2:893-898
23. Armata HL, Golebiowski D, Jung DY, Ko HJ, Kim JK, Sluss HK. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol Cell Biol 2010;30:5787-5794
24. Sluss HK, Armata H, Gallant J, Jones SN. Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol Cell Biol 2004;24:976-984 (Pubitemid 38112163)
25. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-221
26. Maier B, Gluba W, Bernier B, et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 2004;18:306-319 (Pubitemid 38199255)
27. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, et al. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 2002;21:6225-6235 (Pubitemid 35415339)
28. Kim HJ, Higashimori T, Park SY, et al. Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004;53:1060-1067 (Pubitemid 38436619)
29. Borst SE. The role of TNF-Alpha in insulin resistance. Endocrine 2004;23:177-182
30. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119 (Pubitemid 40629025)
31. Turenne GA, Paul P, Laflair L, Price BD. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-Terminal serine residues of p53. Oncogene 2001;20:5100-5110 (Pubitemid 32844038)
32. Hinault C, Kawamori D, Liew CW, et al. Delta40 isoform of p53 controls beta-cell proliferation and glucose homeostasis in mice. Diabetes 2011;60:1210-1222
33. Shoelson SE. Banking on ATM as a new target in metabolic syndrome. Cell Metab 2006;4:337-338 (Pubitemid 44645075)
34. Ungewitter E, Scrable H. Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs. Genes Dev 2010;24:2408-2419
35. Hinault C, Kawamori D, Liew CW, et al. Δ40 isoform of p53 controls β-cell proliferation and glucose homeostasis in mice. Diabetes 2011;60:1210-1222